Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells

Oncogene

Volumn 22, Issue 6, 2003, Pages 826-830

  Kim, Yeonhee ^a   Park, Haein ^a   Lim, Yangmi ^a   Han, Innoc ^b   Ho, Jeong Kwon ^c   Woods, Anne ^d   Oh, Eok Soo ^a  

^a Ewha Womans University   (South Korea)

^b National Cancer Center   (South Korea)

^c Sejong University   (South Korea)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Colon carcinoma; Histone deacetylase syndecan 2; Tumorigenesis

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; HISTONE DEACETYLASE INHIBITOR; SYNDECAN; SYNDECAN 2; TRICHOSTATIN A; UNCLASSIFIED DRUG; UVOMORULIN;

ACTIN FILAMENT; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL CULTURE; CARCINOGENIC ACTIVITY; CELL INTERACTION; CELL STRUCTURE; COLON CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

BETA CATENIN; CADHERINS; CELL ADHESION; CELL COMMUNICATION; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS; PROTEOGLYCANS; SYNDECAN-2; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0037434784     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206068     Document Type: Article

References (19)

1. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL and Lose EJ. (1992). Annu. Rev. Cell. Biol., 8, 365-393.
2. Couchman JR and Woods A. (1999). J. Cell. Sci., 112, 3415-3420.
3. Cress WD and Seto E. (2000). J. Cell. Phys., 184, 1-16.
4. Hoshikawa Y, Kwon HJ, Yoshida M, Horinouchi S and Beppu T. (1994). Exp. Cell. Res. 214, 189-197.
5. Inki P and Jalkanen M. (1996). Ann. Med., 28, 63-67.
6. Jayson GC, Vives C, Paraskeva C, Schofield K, Coutts J, Fleetwood A and Gallagher JT. (1999). Int. J. Cancer., 82, 298-304.
7. Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Yonekura H, Yamamoto H and Okayama M. (2000). Exp. Cell. Res., 256, 434-444.
8. Kwon HJ, Owa T, Hassig CA, Shimada J and Schreiber SL. (1998). Proc. Natl. Acad. Sci. USA. 95, 3356-3361.
9. Leppa S, Mali M, Miettinen H and Jalkanen M. (1992). Proc. Natl. Acad. Sci. USA. 89, 932-936.
10. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T and Kelly WK. (2001). Nat. Rev. Cancer, 1, 194-202.
11. Rachel BH, Greg RP, Rul FQ, Larry N and Stuart AA. (2000). J. Cell. Biol, 148, 779-790.
12. Rapraeger AC. (2000). J. Cell Biol., 149, 995-998.
13. Sealy L and Chalkley R. (1978). Cell, 14, 115-121.
14. Struhl K. (1998). Genes. Dev., 12, 599-606.
15. Sugita K, Koizumi K and Yoshida H. (1992). Cancer Res., 52, 168-172.
16. Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A and Boguslawski KV. (2001). Int. J. Cancer., 95, 1-6.
17. Woods A and Couchman JR. (2000). J. Biol. Chem., 275, 24233-24236.
18. Yoshida M, Kijima M, Akita M and Beppu T. (1990). J. Biol. Chem., 265, 17174-17179.
19. Zimmermann P and David G. (1999). FASEB J., 13, S91-S100.